Skip to search formSkip to main contentSkip to account menu

bimatoprost

Known as: 5-Heptenamide, 7-(3,5-dihydroxy-2-(3-hydrdoxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-, (1R-(1alpha(Z),2beta(1E,3S*),3alpha,5alpha))-, Bimatoprost [Chemical/Ingredient], Bimatoprostum 
A synthetic prostamide and structural prostaglandin analogue with ocular hypotensive activity. Bimatoprost mimics the effects of the endogenous… 
National Institutes of Health

Related topics

Related topics

16 relations

Narrower (3)

AGN 192024LatisseLumigan

Broader (1)

Antihypertensive Agents
Drug AllergyGlaucoma, Open-AngleIn BloodProstaglandins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Spectrofluorometry assays for oxidative stress and apoptosis, with cell viability on the same microplates: a multiparametric analysis and quality control.
2009
2009
Inhibition of cyclooxygenase-2 and EP1 receptor antagonism reduces human colonic longitudinal muscle contractility in vitro.
2009
2009
Expression and functional evidence of the prostaglandin F2alpha receptor mediating contraction in human umbilical vein.
2008
2008
Uveal melanoma masquerading as pigment dispersion glaucoma.
To the Editor: A 64 year old caucasian female presented from an outside ophthalmologist with a history of pigment dispersion… 
2006
2006
The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries
ABSTRACT Objective: The objective of this cost-effectiveness analysis is to evaluate cost-effectiveness ratios of the intraocular… 
2004
2004
Upregulation of orphan nuclear receptor Nur77 following PGF2α, Bimatoprost, and Butaprost treatments. Essential role of a protein kinase C pathway involved in EP2 receptor activated Nur77 gene…
Using gene chip technology, we first identified that PGF2α (FP agonist) and Butaprost (EP2 agonist) induced about a five‐fold… 
2004
2004
Additivity of bimatoprost or travoprost to latanoprost in glaucomatous monkey eyes.
OBJECTIVE To compare the ocular hypotensive effect of the commercially available preparations of bimatoprost or travoprost added… 
2004
2004
Effect of bimatoprost on ocular circulation in patients with open-angle glaucoma or ocular hypertension
PurposeTo study the effect of bimatoprost 0.03% (Lumigan) on ocular hemodynamics in patients with open-angle glaucoma or ocular… 
2003
2003
Ocular hypotensive efficacy of bimatoprost when used as a replacement for latanoprost in the treatment of glaucoma and ocular hypertension.
PURPOSE To evaluate the clinical effectiveness of bimatoprost (Lumigan, Allergan, Inc.) when used as a replacement for… 
2002
2002
Effect of different dose schedules of bimatoprost on intraocular pressure and pupil size in the glaucomatous Beagle.
The changes in intraocular pressure and pupil size in glaucomatous dogs were evaluated after instillations of 0.03% bimatoprost… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)